Active Pharmaceutical Ingredients Market By Therapeutic Application (Oncology, Anti-diabetics, Pulmonology, Immuno-suppressants, Neurology, Cardiology, Ophthalmology, Orthopaedic, Others), By Synthesis Type (Synthetic, Biotech), By Manufacturer (Merchant API, Captive API), By Drug Type (Branded, Generic) Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035
Published Date: Sep 2024 | Report ID: MI1017 | 210 Pages
Report Coverage:
By Therapeutic Application
- Oncology
- Anti-diabetics
- Pulmonology
- Immuno-suppressants
- Neurology
- Cardiology
- Ophthalmology
- Orthopaedic
- Others
By Synthesis Type
- Synthetic
- Biotech
By Manufacturer
- Merchant API
- Captive API
By Drug Type
- Branded
- Generic
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East & Africa
List of Companies:
- Aarti Drugs
- Aurobindo Pharma
- Biocon Ltd
- Cipla, Inc
- Divi's Laboratories Limited
- Dr. Reddy’s Laboratories Ltd
- EUROAPI
- Hikal Ltd
- Merck & Co., Inc.
- Neuland Laboratories Ltd
- Pfizer, Inc
- Qilu Pharmaceutical Co., Ltd
- Solara Active Pharma
- Sun Pharmaceutical Industries Ltd
- Teva Pharmaceutical Industries Ltd
- Novartis International AG
- Roche Holding AG
- Bristol-Myers Squibb
- Boehringer Ingelheim GmbH
- AbbVie Inc.
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.